Skip to main content
. 2009 May 22;3(3):468–479. doi: 10.1007/s12072-009-9134-1

Fig. 1.

Fig. 1

Trial profile. Patients were randomized at week 8 for a total treatment duration of 24 (group A) or 48 (group B) weeks on the basis of the virological response at week 4. Patients who withdrew prematurely from treatment were encouraged to return for follow-up. For this reason, the number of patients who completed follow-up is higher than the number of patients who completed treatment